Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (19)

2022

  1. Early clinical and haemodynamic matched comparison of balloon-expandable valves

    Heart, Vol. 108, Núm. 9, pp. 725-732

2021

  1. Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling (Journal of Molecular Medicine, (2021), 99, 7, (943-953), 10.1007/s00109-021-02054-6)

    Journal of Molecular Medicine

  2. Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

    Journal of Molecular Medicine, Vol. 99, Núm. 7, pp. 943-953

2019

  1. Drug-eluting versus bare-metal stents in primary PCI. Analysis of an 8-year registry

    REC: Interventional Cardiology, Vol. 1, Núm. 1, pp. 26-33

  2. Prognostic impact of the SYNTAX score II in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Analysis of a four-year all-comers registry

    EuroIntervention, Vol. 15, Núm. 9, pp. E796-E803

  3. Tako-tsubo Cardiomyopathy Complicated With Cardiac Tamponade and Cardiogenic Shock

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 351-353

2018

  1. Short-term and long-term validation of the fastest score in patients with ST-elevation myocardial infarction after primary angioplasty

    International Journal of Cardiology, Vol. 269, pp. 19-22

2017

  1. Impella CP-Assisted High-risk Coronary Percutaneous Intervention: First Experience in Spain

    Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 403-405

  2. Intracoronary imaging

    Heart, Vol. 103, Núm. 9, pp. 708-725

  3. Marcapasos transcatéter sin cables Micra. Resultados del implante y seguimiento a medio plazo en un centro

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 275-281

  4. Predictive Value of the SYNTAX Score in Culprit and Nonculprit Vessel Disease. Response

    Revista Espanola de Cardiologia

  5. Revascularización multivaso o solo de la lesión culpable en pacientes con infarto de miocardio con elevación del segmento ST: análisis de un registro a 8 años

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 425-432

2016

  1. Mehran contrast nephropathy risk score: Is it still useful 10 years later?

    Journal of Cardiology, Vol. 67, Núm. 3, pp. 262-267

2015

  1. Comentarios al pronóstico a largo plazo de pacientes con infarto agudo de miocardio sin elevación del segmento ST y arterias coronarias sin estenosis significativa. Respuesta

    Revista Espanola de Cardiologia

  2. Evaluation of SAMe-TT<inf>2</inf>R<inf>2</inf> risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists

    Europace, Vol. 17, Núm. 5, pp. 711-717

  3. Relation of contrast induced nephropathy to new onset atrial fibrillation in acute coronary syndrome

    American Journal of Cardiology, Vol. 115, Núm. 5, pp. 587-591

  4. ¿en la era actual existe beneficio pronóstico del tratamiento con bloqueadores beta tras un síndrome coronario agudo con función sistólica conservada?

    Revista Espanola de Cardiologia, Vol. 68, Núm. 7, pp. 585-591

2014

  1. Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists

    International Journal of Cardiology, Vol. 176, Núm. 3, pp. 1259-1261

  2. Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome?

    Open Heart, Vol. 1, Núm. 1